A copy of our association's 2018-2019 financial statement has been made available for our members to view.
In 2018 BAM conducted a study of the bioscience industry in Manitoba. We took care to measure all aspects of the industry in order to evaluate growth and contribution to the local economy. These are our results.
Several initiatives are underway to position Western Canada as a leading source of high-quality plant protein and related food ingredients. BAM is taking a leadership role in developing the innovation ecosystem to build and grow a strong sector in MB.
On November 21st, 2017, the Life Science Association of Manitoba, in partnership with MEDEC, hosted the Value-Based Health Care in Manitoba: Redesigning the Supply Chain for Success conference.
In 2016 BAM conducted a study of the bioscience industry in Manitoba. We took care to measure all aspects of the industry in order to evaluate growth and contribution to the local economy.
The Real World Evidence (RWE) Report highlights data opportunities present in Manitoba, the uniqueness of the data space and the challenges and potential solutions as discussed at the 2016 RWE Event.
Healthcare occupies a unique position in the lives of Canadians. Not only is it an issue of great personal importance to families, but it has been, and likely always will be, of great significance to elected policy makers.
The 2014 BAM Industry Report is designed to profile Manitoba’s unique bioscience industry and to reveal the Industry’s successes, challenges and future direction.
Manitoba is faced with profound health and socio-economic issues directly related to diabetes. While all demographic groups in the province are affected, northern indigenous populations reported a significantly higher incidence of Type 2 diabetes.